Understanding Assurans
Assurans 20mg by Cipla is a sildenafil citrate research compound designed for investigating phosphodiesterase type 5 (PDE5) inhibition pathways. As a selective PDE5 inhibitor, sildenafil citrate modulates cyclic guanosine monophosphate (cGMP) degradation, making it valuable for cardiovascular and vascular research applications. Scientists examining vasodilation mechanisms and nitric oxide signalling pathways frequently utilise this compound in laboratory studies. The pharmaceutical-grade formulation ensures consistent research outcomes across experimental protocols. Researchers at Stroid UK Shop rely on this compound for studying pulmonary arterial hypertension models and endothelial function investigations.
Scientific Applications
Laboratory investigations with Assurans focus on cardiovascular physiology research, particularly examining smooth muscle relaxation in pulmonary and systemic vascular beds. Research teams study its effects on cGMP-dependent protein kinase activation and subsequent cellular signalling cascades. The compound proves invaluable for investigating nitric oxide-dependent vasodilation mechanisms in isolated vessel preparations. Scientists also examine its interactions with various cardiovascular pharmacological agents in controlled laboratory environments. For comprehensive research portfolios, investigators often combine sildenafil studies with other vasodilatory compounds to understand comparative mechanisms. Advanced research protocols frequently incorporate this compound alongside selective androgen receptor modulators and research peptides for comprehensive physiological studies.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Sildenafil Citrate |
| Strength | 20mg per tablet |
| Manufacturer | Cipla |
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Storage Requirements | Room temperature, dry conditions |
| Research Applications | Cardiovascular physiology studies |
Laboratory Compliance
This Assurans 20mg Cipla sildenafil citrate is manufactured exclusively for in-vitro research applications and laboratory investigations. The compound is not intended for human consumption, therapeutic use, or any applications outside controlled research environments. Researchers must ensure proper laboratory safety protocols and institutional compliance when handling this material. All studies should be conducted under appropriate supervision with proper documentation of experimental procedures and safety measures.
